Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Chibougamau Copper-Gold Project, Canada HIGHLIGHTS: Ongoing resource growth drilling at Cedar Bay has intersected a wide zone of mineralisation in what appears to be a new parallel zone: 28.9m at...
Read More -
Real Estate Expert Kerry Ramage explains the most reliable way for a homeowner to successfully navigate the fast-changing Brevard County market.
Read More
-
Chibougamau Copper-Gold Project, Canada HIGHLIGHTS: Ongoing resource growth drilling at Cedar Bay has intersected a wide zone of mineralisation in what appears to be a new parallel zone: 28.9m at...
-
Washington, D.C., Dec. 07, 2025 (GLOBE NEWSWIRE) -- A former CIA counter-terrorism officer’s recent presentation is urging Americans to understand the full scale of China’s military and...
-
93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell lymphoma in the 3L+ setting83% overall response and 61% complete...
-
All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial response or better) of ≥70% despite limited follow-up; evidence shows that these...
-
CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...
-
Rally House sets new company online single-day sales record following an electric sports weekend and holiday shopping.
-
This white paper exposes how the World Health Organization's FCTC has been captured by NGOs undermining the treaty's credibility.
-
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
-
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
-
WALTHAM, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically...